Associate Director/Director - Associate Director/Director bei Merck: Mitarbeiterbewertung

2,0
7. Apr. 2016
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Newly hired employees can develop and progress if they apply management's philosophy and work hard. Specialization built into the job roles - no longer broad range.

Kontras

The management mindset has changed over the last 20 years. No loyalty to employees any longer. Employees are aware of this philosophy and will not stay long term. The company is not what is was in the years from 1990 to 2005 - the years that blockbuster drugs were developed. Pension plan was terminated and medical benefits have changes applied every year providing less coverage at higher costs.

Mehr Bewertungen zu Merck entdecken

5,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent company to work with.

Kontras

No cons encountered so far

4,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Kontras

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle